Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eledon Pharmaceuticals Inc
ELDNCurrent price
3.24 USD
-0.1 USD (-2.99%)
Last closed
3.36 USD
Company
eledon.com
ISIN
US28617K1016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
201 202 848 USD
Yield for 12 month
+36.71 %
1Y
3Y
5Y
10Y
15Y
ELDN
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California. Address: 19800 MacArthur Boulevard, Irvine, CA, United States, 92612
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.40 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+192 000 USD
Last Quarter
–
Current Year
-374 000 USD
Last Year
-374 000 USD
Current Quarter
+192 000 USD
Last Quarter
–
Key Figures ELDN
1 year
3 years
5 years
10 years
EBITDA
-36 862 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-33.11 %
PEG Ratio
–
Return On Equity TTM
-57.73 %
Wall Street Target Price
10.40 USD
Revenue TTM
–
Book Value
1.98 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.75 USD
Diluted Eps TTM
-0.75 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ELDN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ELDN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:18
Payout Ratio TTM
–
Last Split Date
05.10.2020
Stock Valuation ELDN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
5.39
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.84
Price Book MRQ
1.70
Financials ELDN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ELDN
For 52 weeks
2.00 USD
5.54 USD
50 Day MA
3.60 USD
Shares Short Prior Month
1 373 271
200 Day MA
3.55 USD
Short Ratio
5.53
Shares Short
1 460 007
Short Percent
2.73 %
BeatStart